VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,852 | +1145.4% | 106,000 | +1225.0% | 0.02% | +1500.0% |
| Q4 2022 | $229 | -99.8% | 8,000 | +33.3% | 0.00% | 0.0% |
| Q3 2022 | $145,000 | -11.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $164,000 | -50.3% | 6,000 | -30.2% | 0.00% | 0.0% |
| Q1 2022 | $330,000 | -99.1% | 8,600 | -99.3% | 0.00% | -99.3% |
| Q3 2021 | $38,575,000 | -13.3% | 1,308,953 | 0.0% | 0.14% | -11.7% |
| Q2 2021 | $44,478,000 | -24.6% | 1,308,953 | -27.9% | 0.16% | -34.5% |
| Q1 2021 | $59,007,000 | -13.5% | 1,815,599 | -4.1% | 0.25% | -17.0% |
| Q4 2020 | $68,195,000 | +12.0% | 1,893,242 | +21.8% | 0.30% | -1.0% |
| Q3 2020 | $60,884,000 | +25.9% | 1,554,742 | +17.9% | 0.30% | +17.4% |
| Q2 2020 | $48,358,000 | – | 1,318,377 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |